InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,245.04
(
-0.62%
)
US TECH 100
17,980.00
(
-0.27%
)
Dow Jones
38,295.87
(
-1.01%
)
Brent Oil
78.34
(
-3.06%
)
Bitcoin
69,052.01
(
1.92%
)
Post# of 252020
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 830
Posts 119746
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 161286

Friday, 05/17/2013 3:14:44 PM

Friday, May 17, 2013 3:14:44 PM

Post# of 252020

…Grifols is pursuing the CF indication while Kamada went for the AATD indication as its first target.

Both companies had an orphan designation for hereditary AATD, so GRFS presumably aimed for a different indication to circumvent Kamada’s potential orphan exclusivity.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up